Impact of FCGR3A V158F and FCGR2A H131R Variants on Ofatumumab Efficacy in DLBCL and CLL.Sarah M. Glass,Pamela St Jean,Kay Murphy,Louise Clapham,Eddie Carden,Astrid McKeown,Michele Gorczyca,Oliver Wright,Michael Fennessy,Ira V. Gupta,Colin F. SpraggsJournal of Clinical Oncology（2015）引用 0|浏览76AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
